Jingwen Zheng
  • Jul 15, 2021

Do you know the reactions of Coronavac vaccine?

Instituto Butantan announced the final results of the Phase III clinical trial of China's Coronavac COVID-19 vaccine in Brazil. Today, I will take you to learn more about the specific information.

Introduction

Since the beginning of 2020, people from all over the world have struggled with COVID-19, and scientists are also actively looking for solutions. To achieve herd immunity, the most effective method at the moment can be said to be vaccination. Various voices about the vaccine have also been on the cusp of social public opinion, and the praise or controversy about it has never stopped. A vaccine from theoretical design to clinical trials requires too much wisdom and effort from scientists. Among Chinese vaccines, the most familiar one is Coronavac vaccine, but do you know its adverse reactions?

Instituto Butantan announced the final results of the Phase III clinical trial of China’s Coronavac COVID-19 vaccine in Brazil. Today, I will take you to learn more about the specific information.

Instituto Butantan

Before starting the text, let’s get a general understanding of the Basilis Butantan Institute: It is the largest immunobiology and biopharmaceutical manufacturer in Latin America (and one of the largest in the world), and is considered to be the world’s main science One of the centers. It is world-famous for collecting venomous snakes as well as venomous lizards, spiders, insects and scorpions. By extracting the venom of reptiles and insects, the institute has developed antivenoms and drugs against many diseases, including tuberculosis, rabies, tetanus and diphtheria.

Authorization

Liu Peicheng, Director of Branding and Public Relations of Kexing, said that Kexing’s COVID-19 vaccine has been approved for use in nearly 30 countries and regions, including China, Chile, Brazil, and Turkey, including emergency use, conditional listing or official listing, and has been launched one after another. Large-scale vaccination work. As of April 21, 2021, a total of 160 million doses have been vaccinated globally, including China. The World Health Organization (WHO) approved the emergency use of Kexing COVID-19 vaccine on June 1, 2021.

Data background

20210715-ethnic

20210715-underlying-disease

From July 21 to December 16, 2020, 12842 participants were screened at 16 research sites in Brazil, and 12408 participants were randomly grouped. A total of 12396 participants received at least one dose of Coxing vaccine or placebo, including 6195 in the vaccine group and 6,201 in the placebo group. Among the 12396 participants, 5.1% were elderly participants 60 years or older, 64.2% were women, and most of the participants claimed to be white (75.3%). More than half of the participants (55.9%) had underlying diseases, of which 22.5% were obese (BMI ≥ 30kg/m2). The average age and BMI of the participants were 39.5 years and 26.8 kg/m2, respectively.

Most adverse reactions will occur within 7 days of vaccination

20210715-global-1

Nearly 75% of adverse reactions occur within one week after vaccination, but adverse reactions occur within one hour after vaccination, but the probability is relatively low, about 7%.

20210715-global-2

In the trial population, half of them had adverse reactions with different symptoms and different degrees, and the probability of local reactions (62%) was slightly higher than that of systemic reactions (58%).

Local reaction: A reaction that occurs at the entrance of an infected organism or injection. Systemic reaction: When inflammation spreads from a local area of ​​an organ (such as the skin) to other organ systems in the body, it is called a systemic reaction.

The adverse reactions of the second vaccination were milder than the first

20210715-common-local

Judging from the common reactions after the two inoculations, among the local reactions, the reaction of the second inoculation will be slightly more obvious than the first but the difference is not much. The most common reaction is still pain at the injection site. The probability of this reaction in the second injection has increased by 1.83% compared with the first time. It is also the most likely increase in the probability of these five local reactions. In addition to the above-mentioned common adverse reactions, there are some reactions that will occur with a very small probability. For example, after the first dose of vaccination, there is a 0.1% probability of fever and a 0.06% probability of localized rash. After the second injection, the probability of hardening of the inoculation site, exfoliation of the epidermis, or pustules was less than 0.05%.

20210715-common-systemic

Judging from the common reaction after the two vaccination, in the systemic reaction, the reaction of the second vaccination was mostly weaker than that of the first vaccination. Especially for “headache”, “fatigue” and “nausea”, their chances of appearing decreased by 6.54%, 4.78% and 2% respectively. With regard to vomiting, hypersensitivity reactions, skin rashes, blushing and other adverse reactions, the probability of occurrence is less than 1%. In addition to the above-mentioned common adverse reactions, there are some reactions that will occur with a very small probability. For example, after the first dose of vaccination, there is a 0.42% probability of back pain, 0.26% of oral herpes, 0.19% probability of hyperhidrosis, rhinitis, conjunctivitis, muscle weakness, heart palpitations, etc. less than 1% will occur reaction. After the second injection, there is a 0.46% chance of limb pain, a 0.33% chance of breathing difficulties, a 0.11% chance of edema, and tachycardia, anxiety, pharyngitis, and other reactions less than 1%.

What should I pay attention to after vaccination?

Being vaccinated does not mean that everything will be well and that the virus will not invade. After observing, we still need to pay attention to some things:

  • Avoid eating spicy and irritating foods, seafood foods, and drinking alcohol. It is recommended to drink plenty of water (source: Zhihu)
  • Try to avoid strenuous exercise and keep adequate rest (source: Zhihu)
  • Measures should still be taken to protect yourself and others during travel (Source: CDC)
  • You should still pay attention to the symptoms of COVID-19, especially when you are with patients. If you develop symptoms of COVID-19, you should be tested and self-isolate, stay away from others (Source: CDC)

Conclusion

On the whole, in clinical trials, regardless of the first or second needle, there is a 45% probability that the injection site will feel pain, and there is a 20%-30% probability that you will feel tired or headache. After the second injection, the feeling will not be as obvious as the first injection.

After vaccination, you should pay attention to the light diet and keep adequate rest. Even if you are vaccinated, you must pay attention to protection.

References

Search